Stephanie Lemmo
Papers
3
Total Citations
183
H-Index
3
About
Dr. Stephanie Lemmo is a leading innovator in the development of advanced 3D cell culture microtechnologies for cancer research, with a particular focus on aqueous biphasic systems. Her major contributions center on creating high-throughput platforms that more accurately mimic the tumor microenvironment than traditional 2D cultures. Her seminal 2014 work, "High Throughput, Polymeric Aqueous Two‐Phase Printing of Tumor Spheroids" (93 citations), introduced a novel method using immiscible polymeric solutions to rapidly produce uniform tumor spheroids for anti-cancer drug screening. This foundational technology was further refined in her 2014 optimization study (72 citations), which validated the platform's robustness for 3D drug testing. Dr. Lemmo also pioneered a high-throughput aqueous biphasic migration assay (2013, 18 citations) to screen compounds that inhibit cancer cell motility, a critical step in preventing metastasis. Her work bridges the gap between in vitro models and in vivo physiology, offering powerful tools for accelerating drug discovery. By enabling precise, scalable, and physiologically relevant 3D culture, Dr. Lemmo’s research has significantly advanced the field of cancer biology and therapeutic screening.
Research Focus
Key Achievements
Top Papers
- 1High Throughput, Polymeric Aqueous Two‐Phase Printing of Tumor Spheroids93 citations · 2014
- 2
- 3